ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
about
Low-level expression of human ACAT2 gene in monocytic cells is regulated by the C/EBP transcription factors.New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.Cellular Cholesterol Homeostasis in Alzheimer's Disease.The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.Intracellular Cholesterol Trafficking and Impact in Neurodegeneration.Quantitative Trait Locus Mapping of Macrophage Cholesterol Metabolism and CRISPR/Cas9 Editing Implicate an ACAT1 Truncation as a Causal Modifier Variant.
P2860
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@ast
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@en
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@nl
type
label
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@ast
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@en
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@nl
prefLabel
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@ast
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@en
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@nl
P2093
P2860
P356
P1476
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
@en
P2093
Catherine CY Chang
Ta-Yuan Chang
Yohei Shibuya
P2860
P304
P356
10.4155/FMC.15.161
P407
P577
2015-01-01T00:00:00Z